Gummies are gaining ground as a nutraceutical dosage form, pairing strong consumer appeal with room for product differentiation and a convenient way to deliver supplements.
For formulators, though, a successful gummy depends on far more than flavor. Texture, transparency, processability, ingredient stability, and mouthfeel each shape whether the finished product is one that consumers trust and enjoy.
How galenIQ supports gummy development
BENEO positions its galenIQ excipient as a way to address several of these formulation challenges at once. According to the company, the ingredient offers the following in gummy systems:
- It is much less sensitive than sugar to heat and acid, which BENEO says gives it high stability during the cooking process.
- It forms clear solutions with no off-colors, supporting transparent and visually appealing gummies.
- It delivers a clean, sugar-like taste with no aftertaste, per the company.
- Combined with maltitol syrup, it is said to lower process viscosity, improve depositing, and produce a softer final product with a more elastic texture.
- For the finishing step, the company positions it as a suitable sanding agent.
In summary, BENEO presents galenIQ as enabling stable, sugar-free, and good-tasting gummy formulations with appealing appearance and reliable processing, which the company frames as a preferred excipient choice for modern gummy products. Balancing stability and taste is a recurring challenge across nutraceutical dosage forms, and these are the kind of texture and quality parameters the wider industry is working to standardize.
Gummies stay in focus across the industry
BENEO notes that gummies remained one of the most discussed dosage forms in its customer and partner conversations at Vitafoods Europe 2026, which the company reads as confirmation of growing demand for technically robust, consumer-friendly formats.
BENEO explores those broader 2026 supplement trends in episode 18 of its Excipient Talk podcast, where host Dr. Michael Black is joined by Monica Holmes, the company’s market intelligence and consumer insights expert. They discuss global consumer priorities, including demand for science-backed benefits, the rise of convenient and tasty supplement formats, and a growing focus on gut health, energy, and metabolic wellness.
Where to meet the galenIQ team
BENEO’s galenIQ team will be at CPHI China 2026, running June 16 to 18, to discuss formulation trends, functional excipients, and opportunities in consumer-friendly dosage forms such as gummies. Companies exploring new nutraceutical concepts or looking for technical formulation support can arrange to meet the team there by contacting Tai Chiem at BENEO.
For formulators who want to continue the conversation on gummy development, BENEO provides more information, samples, and formulation support on request through LinkedIn or directly at [email protected]. The company also shares ongoing formulation tips and application examples through its galenIQ newsletter, with further technical detail on its pharmaceutical excipients website.
Sources
- Primary source: BENEO, “Gummies in nutraceuticals: formulation matters,” LinkedIn, May 26, 2026.
- BENEO, “Pharmaceutical Excipients” (galenIQ),
Read more on gummy formulation here:
Antidepressant Efficacy of Nutraceutical Gummies: Formulation of Withania Somnifera and Valeriana officinalis Evaluated in Forced Swim Test Model
Ingredients insights. Straight to your inbox. Subscribe now.
